The Australian TGA Direction on Equivalence of Herbal Extracts in Complementary Medicines (Australian Government. Office of Health, 2011) identifies the following as many of the components that affect the phytoequivalence of extracts: commencing substance top quality, solvent selections, and production procedures which include time and temperature.